1. Academic Validation
  2. TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24/LXR pathway in microglia

TREM2 alleviates white matter injury after traumatic brain injury in mice might be mediated by regulation of DHCR24/LXR pathway in microglia

  • Clin Transl Med. 2024 Apr;14(4):e1665. doi: 10.1002/ctm2.1665.
Zhao Li 1 2 Shenghui Yu 2 Lin Li 3 Chao Zhou 2 Lin Wang 1 4 Shuang Tang 1 5 Nina Gu 1 Zhaosi Zhang 1 Zhijian Huang 1 Hong Chen 1 Wei Tang 1 Yingwen Wang 1 Xiaomin Yang 1 Xiaochuan Sun 1 Jin Yan 1
Affiliations

Affiliations

  • 1 Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • 2 Emergency Department, Chengdu First People's Hospital, Chengdu, China.
  • 3 Department of Neurosurgery, Chongqing University Cancer Hospital, Chongqing, China.
  • 4 Department of Neurosurgery, Nanchong Central Hospital, The Second Clinical Medical College of North Sichuan Medical College, Nanchong, China.
  • 5 Department of Neurosurgery, Suining Central Hospital, Suining, China.
Abstract

Background: White matter injury (WMI) is an important pathological process after traumatic brain injury (TBI). The correlation between white matter functions and the myeloid cells expressing triggering receptor-2 (TREM2) has been convincingly demonstrated. Moreover, a recent study revealed that microglial sterol metabolism is crucial for early remyelination after demyelinating diseases. However, the potential roles of TREM2 expression and microglial sterol metabolism in WMI after TBI have not yet been explored.

Methods: Controlled cortical injury was induced in both wild-type (WT) and TREM2 depletion (TREM2 KO) mice to simulate clinical TBI. COG1410 was used to upregulate TREM2, while PLX5622 and GSK2033 were used to deplete microglia and inhibit the liver X receptor (LXR), respectively. Immunofluorescence, Luxol fast blue staining, magnetic resonance imaging, transmission electron microscopy, and oil red O staining were employed to assess WMI after TBI. Neurological behaviour tests and electrophysiological recordings were utilized to evaluate cognitive functions following TBI. Microglial cell sorting and transcriptomic sequencing were utilized to identify alterations in microglial sterol metabolism-related genes, while western blot was conducted to validate the findings.

Results: TREM2 expressed highest at 3 days post-TBI and was predominantly localized to microglial cells within the white matter. Depletion of TREM2 worsened aberrant neurological behaviours, and this phenomenon was mediated by the exacerbation of WMI, reduced renewal of oligodendrocytes, and impaired phagocytosis ability of microglia after TBI. Subsequently, the upregulation of TREM2 alleviated WMI, promoted oligodendrocyte regeneration, and ultimately facilitated the recovery of neurological behaviours after TBI. Finally, the expression of DHCR24 increased in TREM2 KO mice after TBI. Interestingly, TREM2 inhibited DHCR24 and upregulated members of the LXR pathway. Moreover, LXR inhibition could partially reverse the effects of TREM2 upregulation on electrophysiological activities.

Conclusions: We demonstrate that TREM2 has the potential to alleviate WMI following TBI, possibly through the DHCR24/LXR pathway in microglia.

Keywords

DHCR24; LXR; TREM2; microglia; oligodendrocyte precursor cells; oligodendrocytes; sterol metabolism; traumatic brain injury; white matter injury.

Figures
Products